GlassScriptPhysician profile
Jasmine Benson
NPI 1982194874
$1,329.27
in general payments reported to CMS, 2019-2025
27 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $136 · 2023: $139 · 2024: $253 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $211.98 | 2024-2025 | Camzyos, Eliquis |
| Abbvie INC. | $151.80 | 2021 | |
| Abbott Laboratories | $75.72 | 2024-2025 | Cardiomems |
| Novo Nordisk INC | $69.90 | 2021-2025 | Wegovy |
| Bioventus LLC | $64.90 | 2025 | Durolane |
| Pfizer INC. | $64.72 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.83 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.71 | 2021-2023 | Jardiance, Spiriva Respimat |
| Medtronic, INC. | $56.02 | 2023 | Linq II |
| Novartis Pharmaceuticals Corporation | $50.71 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $45.55 | 2022 | |
| Itamar Medical INC | $44.75 | 2025 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $44.74 | 2024-2025 | |
| Scpharmaceuticals INC. | $41.18 | 2025 | |
| Abiomed | $34.96 | 2024 | Impella |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $33.72 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $28.88 | 2022-2023 | Farxiga |
| Eisai INC. | $26.44 | 2021-2022 | |
| Baxter Healthcare | $25.21 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $24.05 | 2024 | |
| Boston Scientific Corporation | $19.33 | 2025 | Watchman Access System |
| Impulse Dynamics (USA) INC. | $19.31 | 2025 | Optimizer |
| Zimmer Biomet Holdings, INC. | $17.73 | 2025 | Gps III Platelet Concentration System |
| Exact Sciences Corporation | $16.07 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $13.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.01 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.